Vitamin d deficiency impacts on expression of toll-like receptor-2 and cytokine profile: A pilot study

Journal of Translational Medicine

Volumn 11, Issue 1, 2013, Pages

  Ojaimi, Samar ^a   Skinner, Narelle A ^b,c   Strauss, Boyd J G ^b   Sundararajan, Vijaya ^b   Woolley, Ian ^a,b   Visvanathan, Kumar ^a,b,c  

^a Southern Health ^*  (Australia)

^b MONASH UNIVERSITY   (Australia)

^c UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

Immunity; Innate immunity; Toll like receptor; Vitamin D; Vitamin D deficiency

Indexed keywords

ALPHA INTERFERON; CD86 ANTIGEN; GAMMA INTERFERON INDUCIBLE PROTEIN 10; INTERLEUKIN 6; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 4; TUMOR NECROSIS FACTOR ALPHA; VITAMIN D; CYTOKINE; LIGAND; TLR2 PROTEIN, HUMAN;

ADULT; ANTIGEN EXPRESSION; ARTICLE; AUSTRALIA; CELL STIMULATION; CYTOKINE PRODUCTION; EX VIVO STUDY; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN EXPERIMENT; INNATE IMMUNITY; LONGITUDINAL STUDY; MALE; NORMAL HUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; PROSPECTIVE STUDY; PROTEIN EXPRESSION; SINGLE DRUG DOSE; VITAMIN BLOOD LEVEL; VITAMIN D DEFICIENCY; VITAMIN SUPPLEMENTATION; BLOOD; CELL DIFFERENTIATION; CELL PROLIFERATION; DIET SUPPLEMENTATION; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION REGULATION; IMMUNOLOGY; INFLAMMATION; METABOLISM; PILOT STUDY;

ADULT; CELL DIFFERENTIATION; CELL PROLIFERATION; CHEMOKINE CXCL10; CYTOKINES; DIETARY SUPPLEMENTS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; GENE EXPRESSION REGULATION; HUMANS; IMMUNITY, INNATE; INFLAMMATION; INTERFERON-ALPHA; INTERLEUKIN-6; LIGANDS; LONGITUDINAL STUDIES; MALE; PILOT PROJECTS; PROSPECTIVE STUDIES; TOLL-LIKE RECEPTOR 2; TUMOR NECROSIS FACTOR-ALPHA; VITAMIN D; VITAMIN D DEFICIENCY;

EID: 84880334803     PISSN: None     EISSN: 14795876     Source Type: Journal    
DOI: 10.1186/1479-5876-11-176     Document Type: Article

References (29)

1. Bickle D. Nonclassic Actions of Vitamin D. J Clin Endocrinol Metab 2009, 94:26-34. 2630868, 18854395.
2. Holick MF. Vitamin D: Extraskeletal Health. Endocrinol Metab Clin N Am 2010, 39:381-400.
3. Souberbielle JC, Body JJ, Lappe JM, Plebani M, Shoenfeld Y, Wang TJ, et al. Vitamin D and musculoskeletal health, cardiovascular disease, autoimmunity and cancer: Recommendations for clinical practice. Autoimmun Rev 2010, 9:709-715. 10.1016/j.autrev.2010.06.009, 20601202.
4. Binkley N, Ramamurthy R, Krueger D. Low Vitamin D Status: Definition, Prevalence, Consequences, and Correction. Endocrinol Metab Clin N Am 2010, 39:287-301.
5. Maalouf NM. The noncalciotropic actions of vitamin D: recent clinical developments. Curr Opin Nephrol Hyperten 2008, 17:408-415.
6. Adams JS, Liu PT, Chun R, Modlin RL, Hewison M. VitaminD in Defense of the Human Immune Response. Ann N Y Acad Sci 2007, 1117:94-105. 10.1196/annals.1402.036, 17656563.
7. Litonjua AA, Weiss ST. Is vitamin D deficiency to blame for the asthma epidemic?. J Allergy Clin Immunol 2007, 120:1031-1035. 10.1016/j.jaci.2007.08.028, 17919705.
8. Reichrath J. Vitamin D, and the skin: an ancient friend, revisited. Exp Dermatol 2007, 16:618-625. 10.1111/j.1600-0625.2007.00570.x, 17576242.
9. Do JE, Kwon SY, Park S, Lee ES. Effects pf vitmain D on expression of Toll-like receptors of monocytes from patients with Behçet's disease. Rheumatology 2008, 47:840. 10.1093/rheumatology/ken109, 18411217.
10. Bekeredjian-Ding I, Jego G. Toll-like receptors - sentries in the B-cell response. Immunology 2009, 128:311-323. 10.1111/j.1365-2567.2009.03173.x, 2770679, 20067531.
11. McCormack WJ, Parker AE, O'Neill LA. Toll-like receptors and NOD-like receptors in Rheumatic Diseases. Arthritis Res & Therapy 2009, 11:243-251. 10.1186/ar2729, 23901209.
12. Muzio M, Mantovani A. Toll-like receptors. Microbes and Infection 2000, 2:251-255. 10.1016/S1286-4579(00)00303-8, 10758401.
13. Rau FC, Dieter J, Luo Z, Priest SO, Baumgarth N. B7-1/2 (CD80/CD86) Direct Signalling to B Cells Enhances IgG Secretion. J Immunol 2009, 183:7661-7671. 10.4049/jimmunol.0803783, 2795108, 19933871.
14. Sadeghi K, Wessner R, Laggner U, Ploder M, Tamandl D, Josef F, et al. Vitamin D3 down-regulates monocyte TLR expression and triggers hyporesponsiveness to pathogen-associated molecular pattern. Eur J Immunol 2006, 36:361-379. 10.1002/eji.200425995, 16402404.
15. Christakos S, Ajibade DV, Dhawan P, Fechner AJ, Mady LJ. Vitamin D: Metabolism. Enodcrinol Metab Clin N Am 2010, 39:243-253.
16. Mosekilde L. Vitamin D, requirement and setting recommendation levels: long-term perspectives. Nutr Rev 2008, 66:S170-S177.
17. Muscogiuri G, Sorice GP, Prioletta A, Policola C, Della Casa S, Pontecorvi A, et al. 25-Hydroxyvitamin D Concentration Correlates with Insulin-Sensitivity and BMI in obesity. Obesity 2010, 18:1906-1910. 10.1038/oby.2010.11, 20150902.
18. Holick MF, Vitamin D. Status: Measurement, Interpretation, and Clinical Application. Ann Epidemiol 2008, 19:73-78. 2665033, 18329892.
19. Vashi PG, Lammersfeld CA, Braun DP, Gupta D. Serum 25-hydroxyvitamin D is inversely associated with body mass index in cancer. Nutr J 2011, 10:51-57. 10.1186/1475-2891-10-51, 3112404, 21575232.
20. Konradsen S, Ag H, Lindberg F, Hexeberg S, Jorde R. Serum 1,25-dihydroxy vitamin D is inversely associated with body mass index. Eur J Nutr 2008, 47:87-91. 10.1007/s00394-008-0700-4, 18320256.
21. Heaney RP. Vitamin D: criteria for safety and efficacy. Nutr Rev 2008, 66:S178-S181.
22. Nursyam EW, Amin Z, Rumende CM. The Effect of Vitamin D as Supplementary Treatment in Patients wiht Modertely Advanced Pulmonary Tuberculous lesion. Acta Med Indones 2006, 38:3-5.
23. Martineau AR, Timms PM, Bothamley GH, Hanifa Y, Islam K, Claxton AP, et al. High-dose vitamin D3 during intensive-phase antimicrobial treatment of pulmonary tuberculosis: a double-blind randomised controlled trial. Lancet 2011, 377:242-250. 10.1016/S0140-6736(10)61889-2, 21215445.
24. Hollis BW. Assessment and Interpretation of Circulating 25-Hydroxyvitamin D and 1,25-Dihydroxyvitamin D in the clinical environment. Endocrinol Metab Clin N Am 2010, 39:271-286.
25. Adams JS, Ren S, Liu PT, Chun RF, Lagishetty V, Gombart AF, et al. Vitamin D-Directed Rheostatic Regulation of Monocyte Antibacterial Responses. J Immunol 2009, 182:4289-4295. 10.4049/jimmunol.0803736, 2683618, 19299728.
26. Liu PT, Stenger S, Li H, Wenzel L, Tan BH, Krutzik SR, et al. Toll-like Receptor Triggering of a Vitamin D-Mediated Human Antimicrobial Response. Science 2006, 311:1770-1773. 10.1126/science.1123933, 16497887.
27. Walker VP, Zhang X, Rastegar I, Liu P, Hollis BW, Adams JS, et al. Cord Blood Vitamin D Status Impacts Innate Immity Responses. J Endocrinol Metab 2011, 96:1835-1843.
28. Bikle DD. Vitamin D, and the immune system: role in protection against bacterial infection. Curr Opin Neprhol Hypertens 2008, 17:348-352.
29. Mahon BD, Gordon SA, Cruz J, Cosman F, Cantorna MT. Cytokine profile in patients with Multiple Sclerosis following vitamin D supplementation. J Neuroimmunology 2003, 134:128-132.